Latest US News
29-Jul-2010
22-Feb-2010
Novartis receives FDA approval of Menveo®, a vaccine to prevent meningococcal disease
21-Dec-2009
24-Nov-2009
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
06-Oct-2009
Novartis completes shipment of US supply of Fluvirin® seasonal influenza vaccine
Caring Begins with Prevention
At Novartis Vaccines, our purpose is protecting individuals from infection in the first place. Even as healthcare access improves worldwide, societies continue to battle age-old infectious diseases and face the challenges of newly emerging threats.
Novartis Vaccines is committed to advancing the science of disease prevention and our innovative vaccines are designed to prevent the spread of life-threatening communicable diseases, protect vulnerable populations and keep healthy people healthy.
To deliver on the promise of prevention, we aspire to address unmet needs by driving new industry standards in product innovation, quality and reliability.
U.S. HEALTHCARE PROVIDERS
For U.S. Healthcare Providers ordering Novartis vaccines just got easier. Now you can:
- manage inventory
- check order status
- track vaccine orders
- learn about online discounts.
Your New online order portal for vaccines is just a click away.
US Medical Communications
US Medical Communications is the point of contact should you require further information about our marketed vaccine products, or have an adverse event reaction to report. Business hours are 9:00am - 5:30pm Eastern Time. Call or submit your question online.
1-800-244-7668